CHMP recommends marketing authorization for Frehemgo, Vaxrabeo, Adcomfo, Pebrilzo
EMA's CHMP recommended granting marketing authorization for Frehemgo, Vaxrabeo, Adcomfo, and Pebrilzo.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.